These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 11446362

  • 1. Trends in ciprofloxacin nonsusceptibility and levofloxacin resistance among Streptococcus pneumoniae isolates in North America.
    Karlowsky JA, Nealy L, Sahm DF, Thornsberry C, Jones ME.
    J Clin Microbiol; 2001 Jul; 39(7):2748-50. PubMed ID: 11446362
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative activities of ciprofloxacin and levofloxacin against Streptococcus pneumoniae in an In vitro dynamic model.
    Zinner SH, Simmons K, Gilbert D.
    Antimicrob Agents Chemother; 2000 Mar; 44(3):773-4. PubMed ID: 10681356
    [Abstract] [Full Text] [Related]

  • 7. Antipneumococcal activity of ulifloxacin compared to levofloxacin and ciprofloxacin.
    Pallecchi L, Riccobono E, Montagnani F, Di Maggio T, Mantengoli E, Pollini S, Rossolini GM.
    J Chemother; 2011 Oct; 23(5):308-9. PubMed ID: 22005066
    [No Abstract] [Full Text] [Related]

  • 8. Comparative in vitro activity of levofloxacin, ofloxacin, and ciprofloxacin against ocular streptococcal isolates.
    Miller D, Alfonso EC.
    Cornea; 2004 Apr; 23(3):289-93. PubMed ID: 15084863
    [Abstract] [Full Text] [Related]

  • 9. Streptococcus pneumoniae killing rate and post-antibiotic effect of levofloxacin and ciprofloxacin.
    Fuchs PC, Barry AL, Brown SD.
    J Chemother; 1997 Dec; 9(6):391-3. PubMed ID: 9491837
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobial resistance of Streptococcus pneumoniae isolates in 1999 and 2000 in Madrid, Spain: a multicentre surveillance study.
    Oteo J, Alós JI, Gómez-Garcés JL.
    J Antimicrob Chemother; 2001 Feb; 47(2):215-8. PubMed ID: 11157911
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations.
    Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Rice CL, Doern GV.
    Clin Infect Dis; 2005 Jan 15; 40(2):225-35. PubMed ID: 15655739
    [Abstract] [Full Text] [Related]

  • 15. Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America.
    Johnson CN, Benjamin Jr WH, Moser SA, Hollingshead SK, Zheng X, Crain MJ, Nahm MH, Waites KB.
    J Clin Microbiol; 2003 Jun 15; 41(6):2458-64. PubMed ID: 12791865
    [Abstract] [Full Text] [Related]

  • 16. Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000.
    White RL, Enzweiler KA, Friedrich LV, Wagner D, Hoban D, Bosso JA.
    Diagn Microbiol Infect Dis; 2002 Jul 15; 43(3):207-17. PubMed ID: 12106954
    [Abstract] [Full Text] [Related]

  • 17. Activity of oral agents against pediatric isolates of Streptococcus pneumoniae.
    Black J, Moland ES, Chartrand SA, Thomson KS.
    Diagn Microbiol Infect Dis; 2001 Mar 15; 39(3):195-7. PubMed ID: 11337189
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In-vitro bacteriostatic activity of levofloxacin and three other fluoroquinolones against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Frémaux A, Sissia G, Geslin P.
    J Antimicrob Chemother; 1999 Jun 15; 43 Suppl C():9-14. PubMed ID: 10404331
    [Abstract] [Full Text] [Related]

  • 20. Determining the frequency of resistance of Streptococcus pneumoniae to ciprofloxacin, levofloxacin, trovafloxacin, grepafloxacin, and gemifloxacin.
    Evans ME.
    Eur J Clin Microbiol Infect Dis; 2001 Dec 15; 20(12):883-5. PubMed ID: 11837640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.